Trojan horses for drugs: a new role for lipoproteins?
aDipartimento di Scienze e Tecnologie Biologiche e Ambientali, Università del Salento & UdR INSTM di Lecce bIstituto di Nanotecnologia CNR-Nanotec, Lecce, Italy cDepartment of Genetic Engineering, CINVESTAV Irapuato Unit, Irapuato dDepartment of Medical Sciences, Division of Health Sciences, Leon Campus, University of Guanajuato, Leon, Guanajuato, Mexico.
Giuseppe
G
Ciccarella
Gertrud
G
Lund
Silvio
S
Zaina
D000818:Animals; D002318:Cardiovascular Diseases / Q000517:prevention & control; D004281:Docosahexaenoic Acids / Q000008:administration & dosage / Q000737:chemistry; D006801:Humans; D008074:Lipoproteins / Q000008:administration & dosage / Q000737:chemistry; D053758:Nanoparticles / Q000008:administration & dosage
D008074:Lipoproteins; D004281:Docosahexaenoic Acids